Why US federal health agencies are abandoning mRNA vaccines

Published: Friday, August 15, 2025 at 9:00 am

US Health Agencies Shift Away from mRNA Vaccines

Washington, D.C. - The US government, a key player in the initial development and deployment of mRNA vaccines, appears to be retreating from its support of the technology. This shift is marked by a withdrawal of funding, the termination of partnerships, and growing skepticism from leaders within US health agencies regarding the vaccines' efficacy and safety.

The government's initial investment in mRNA vaccine development was substantial, totaling $18 billion through Operation Warp Speed. This funding accelerated the research and development process, enabling the rapid creation of vaccines in response to the COVID-19 pandemic. The speed of development was unprecedented, with vaccines being administered within a year of the virus's genetic code being sequenced, a stark contrast to the typical decade-long drug development timeline.

Early clinical trials demonstrated promising results. The Pfizer-BioNTech vaccine, for example, showed approximately 95% protection against COVID-19 in initial trials involving tens of thousands of volunteers. Despite these positive outcomes, the vaccines have faced criticism.

The director of the National Institutes of Health has suggested that the shift away from mRNA vaccines is due to a lack of public trust in the technology.

BNN's Perspective: The decision by US health agencies to distance themselves from mRNA vaccines is a complex one. While the initial rollout of these vaccines was undeniably rapid and effective in the face of a global health crisis, the ongoing debate surrounding their long-term effects and the rise of vaccine hesitancy necessitates a cautious approach. It is crucial for health agencies to balance the need for public health protection with the importance of maintaining public trust and transparency. Further research and open communication are essential to address concerns and ensure informed decision-making regarding future vaccine strategies.

Keywords: mRNA vaccines, US government, funding, partnerships, health agencies, efficacy, safety, COVID-19, Operation Warp Speed, Pfizer-BioNTech, public trust, vaccine hesitancy

Full Story